Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-01-2015 | Review – Cancer Research

Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies

Authors: Qian Feng, Yugang Chi, Yanqian Liu, Ling Zhang, Qi Liu

Published in: Journal of Cancer Research and Clinical Oncology | Issue 1/2015

Abstract

Purpose

The aim of our meta-analysis was to compare the efficacy and safety of radiofrequency ablation (RFA) versus surgical resection for patients with small hepatocellular carcinoma (SHCC).

Methods

Randomized controlled trials (RCTs) or retrospective studies comparing the RFA with surgical resection for patients with SHCC published from 2004 to 2014 were selected from database of PubMed, EMBASE and Cochrane library. The outcomes including overall survival rate, recurrence-free survival rate, recurrence rate and complications (mortality rate and morbidity rate) were abstracted. Individual and pooled odds ratio with 95 % confidence interval of each outcome was analyzed.

Results

Three RCTs and twenty retrospective studies were included with a total of 15,482 patients. The 1-, 3- and 5-year overall survival rate and recurrence-free survival rate of surgical resection were significantly higher than RFA. The 2- and 3-year but not 1-year recurrence rate of RFA was significantly higher than surgical resection. The morbidity rate of complication in surgical resection group was higher than it in RFA group, but the mortality was not different between the two groups.

Conclusion

Surgical resection led to a higher overall survival and recurrence-free survival rate in treating SHCC. However, RFA led to a lower morbidity rate of complication than surgical resection.

Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12:1521–1526PubMedCrossRef

Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328PubMedCentralPubMedCrossRef

Cho YK, Rhim H, Noh S (2011) Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review. J Gastroenterol Hepatol 26:1354–1360PubMed

Desiderio J, Trastulli S, Pasquale R, Cavaliere D, Cirocchi R, Boselli C, Noya G, Parisi A (2013) Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 398:55–62CrossRef

Duffy JP, Hiatt JR, Busuttil RW (2008) Surgical resection of hepatocellular carcinoma. Cancer J 14:100–110PubMedCrossRef

Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J (2012) A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 57:794–802PubMedCrossRef

Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D’Onofrio M, Martone E, Nicoli P, Iacono C (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198PubMedCrossRef

Guo WX, Sun JX, Cheng YQ, Shi J, Li N, Xue J, Wu MC, Chen Y, Cheng SQ (2013) Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma. World J Surg 37:602–607PubMedCrossRef

Hasegawa K, Kokudo N, Makuuchi M, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O et al (2013) Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 58:724–729PubMedCrossRef

Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y et al (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55:2171–2174PubMed

Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912PubMedCrossRef

Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, Kao WY, Huo TI, Huang YH, Su YH et al (2011) Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 9:79–86PubMedCrossRef

Ikeda K, Kobayashi M, Kawamura Y, Imai N, Seko Y, Hirakawa M, Hosaka T, Sezaki H, Akuta N, Saitoh S et al (2011) Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model. Liver Intern 31:692–699CrossRef

Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H (2012) Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less. Hepatol Res 43:853–864CrossRef

Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFASG (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644PubMedCrossRef

Kong WT, Zhang WW, Qiu YD, Zhou T, Bin H (2011) Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma. Chin-Ger J Clin Oncol 10(7):399–405CrossRef

Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(Suppl 1):113–124PubMedCrossRef

Li L, Zhang J, Liu X, Li X, Jiao B, Kang T (2012) Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a meta-analysis. J Gastroenterol Hepatol 27:51–58PubMedCrossRef

Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917PubMedCrossRef

Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB 9:429–434PubMedCentralPubMedCrossRef

Marrero JA (2013) Multidisciplinary management of hepatocellular carcinoma: where are we today? Semin Liver Dis 33(Suppl 1):S3–S10PubMed

Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC et al (2003) Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17:1247–1261PubMedCrossRef

Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, et al (2011) Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 11:143PubMedCentralPubMedCrossRef

Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS (2012) Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–1033PubMedCrossRef

Pompili M, Saviano A, de Matthaeis N, Cucchetti A, Ardito F, Federico B, Brunello F, Pinna AD, Giorgio A, Giulini SM, et al (2013) Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma 3 cm. Results of a Multicenter Italian Survey. J Hepatol 59:89–97PubMedCrossRef

Rhim H, Lim HK (2010) Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 4(Suppl 1):S113–S118PubMedCentralPubMedCrossRef

Rhim H, Lim HK, Choi D (2010) Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2:128–136PubMedCentralPubMedCrossRef

Sung NH, Lee SY, Moon SC, Joon HL, Kwang CK, Seung WP, Byung CY, Jong CR, Choi D, Hyo KL et al (2005) Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 39:247–252CrossRef

Tohme S, Geller DA, Cardinal JS, Chen HW, Packiam V, Reddy S, Steel J, Marsh JW, Tsung A (2013) Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma. HPB 15:210–217PubMedCentralPubMedCrossRef

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H, Kagoshima Liver Cancer Study Group (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef

Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5–13PubMedCrossRef

Wang JH, Wang CC, Hung CH, Chen CL, Lu SN (2012) Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 56:412–418PubMedCrossRef

Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY, et al (2012) Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol 32:253–257PubMedCrossRef

Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y, Miao Y (2012) Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol 10:163PubMedCentralPubMedCrossRef

Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRef

Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, Jang TH, Lee JH, Koh KC, Paik SW et al (2011) Superior long-term outcomes after surgery in child–pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 5:722–729PubMedCentralPubMedCrossRef

Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, Yang J (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 10:78PubMedCentralPubMedCrossRef

Title: Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies
Authors: Qian Feng
Yugang Chi
Yanqian Liu
Ling Zhang
Qi Liu
Publication date: 01-01-2015
Publisher: Springer Berlin Heidelberg
Published in: Journal of Cancer Research and Clinical Oncology / Issue 1/2015
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-014-1708-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies

Abstract

Purpose

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study

CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression

Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer

Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer

Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer

Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page